Table 2.

Results of autologous hematopoietic stem cell transplantation in patients with systemic lupus erythematosus

ReferenceNo. of patients receiving transplantsRegimenResultsMortality
Marmont et al199 TT/Cy Clinical remission for more than 3 y, serologic relapse 0  
Burt et al179 183 
Traynor et al181 
Cy/ATG Clinical remission for up to 4 y, 2 relapsed at 3 y and 3.5 y, respectively 1/12 mobilized 
Fouillard et al192 BEAM Clinical remission for 1 y; ANA negative at 6 mo but positive at 9 mo 0  
Rosen et al188 Cy/ATG Complete remission of active disease 0  
Musso et al185 Cy/ATG Posttransplantation low ANA titer and low Coombs positive at 8 mo but anti-ds DNA negative and anticardiolipin antibody negative 
ReferenceNo. of patients receiving transplantsRegimenResultsMortality
Marmont et al199 TT/Cy Clinical remission for more than 3 y, serologic relapse 0  
Burt et al179 183 
Traynor et al181 
Cy/ATG Clinical remission for up to 4 y, 2 relapsed at 3 y and 3.5 y, respectively 1/12 mobilized 
Fouillard et al192 BEAM Clinical remission for 1 y; ANA negative at 6 mo but positive at 9 mo 0  
Rosen et al188 Cy/ATG Complete remission of active disease 0  
Musso et al185 Cy/ATG Posttransplantation low ANA titer and low Coombs positive at 8 mo but anti-ds DNA negative and anticardiolipin antibody negative 

TT/Cy indicates thiotepa and cyclophosphamide; Cy/ATG, cyclophosphamide and antithymocyte globulin; BEAM, carmustine, etoposide, cytarabine, melphalan; ANA, antinuclear antibody; and anti-ds, anti–double strand DNA antibody.

Close Modal

or Create an Account

Close Modal
Close Modal